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DNP Project Title
Educating Anesthesia Providers on Sphenopalatine Ganglion Block as Post Dural
Puncture Headache Treatment.
Abstract
Background: Post-dural puncture headache (PDPH) is a possible adverse effect of some spinal
and neuraxial anesthesia procedures; it is characterized by visual disturbances, nausea,
vomiting, dizziness, photophobia, and a postural component occurring within five days of a
dural puncture. The epidural blood patch (EBP) has been considered the standard treatment for
PDPH; however, the EBP has a considerable number of risks due to its invasive nature. The
Sphenopalatine Ganglion Block (SPGB) is a non-invasive alternative therapy that shows
promise in the treatment of PDPH.
Methods: A thorough search of research was performed utilizing MEDLINE (ProQuest) and
CINAHL to distinguish research studies published within the past five years that have assessed
the efficacy of the sphenopalatine ganglion block as a treatment for post-dural puncture
headaches.
Results: Five published studies were classified as appropriate for analysis. The studies evaluated
sphenopalatine ganglion block as an alternative to conservative treatment for post-dural
puncture headache.

Keywords: Sphenopalatine Ganglion Block, Post Dural Puncture Headache
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Introduction
Problem Identification
Neuraxial analgesia is the most frequent type of anesthesia delivered in the United States
in obstetrics.1 The most common complication arising from neuraxial labor analgesia is Post
Dural Puncture Headache (PDPH).1 Obstetric patients have a higher possibility of developing
this condition because they possess many patient-specific risk factors; these include young age,
female sex, pregnancy, vaginal delivery, and non-smoking status.2 Typically, the PDPH resolves
on its own; however, it can cause substantial morbidity in the postpartum patient and can
interfere considerably with the mother’s capability to care for her newborn or herself.2
Currently, the definitive treatment for postnatal PDPH is the epidural blood patch (EBP).3
The EBP is not only an invasive treatment option, but it is also not without inherent risks; while
uncommon, EBP treatment can lead to an additional accidental dural puncture, acute or chronic
back pain, arachnoiditis, spinal hematoma, meningitis, cerebral hemorrhage, or cerebral
ischemia.4 Numerous alternative treatments for PDPH exist, ranging from conservative, such as
bed rest, caffeine, and oral analgesic medication administration, to invasive, including
acupuncture, epidural morphine, and greater occipital nerve blocks. Due to the invasive nature of
the current gold standard treatment and the potential side effects, alternate, less invasive, less
hazardous treatment modalities should be utilized. One promising, minimally invasive, low-risk
alternative to the EBP is the sphenopalatine ganglion block (SPGB).3 The purpose of this project
is to enhance the knowledge of obstetric anesthesia providers regarding the use of sphenopalatine
ganglion blocks in the treatment of post-dural puncture headaches.
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Background
All across America, the use of neuraxial labor analgesia has risen.1 It is the most
frequently used technique for pain relief of laboring mothers, with nearly 75% of vaginal
delivery patients and almost 90% of cesarean delivery patients receiving epidural or spinal
anesthesia.5 The use of an epidural for a vaginal delivery is a versatile technique allowing for an
easy transition to the operating room if urgent obstetrical intervention is necessary or the delivery
needs to be emergently converted to a cesarean delivery; this reduces the occurrence of general
anesthesia when critical interventions are required.1 Similarly, spinal anesthesia is the most
extensively utilized anesthetic for planned cesarean sections; it is relatively safe, reliable, easy to
administer, has a rapid onset, and is low cost.6 Based on these statistics, roughly two million
women in the United States undergo procedures with the placement of neuraxial analgesia.5
PDPH is more commonly caused by an accidental dural puncture from an epidural
catheter placement than a spinal anesthetic; the reason for this is the gauge and type of needle
used for the different procedures, spinals are performed using a small, pencil tip needle, whereas
epidurals are performed using a larger gauge Tuohy needle.2 When an accidental dural puncture
is recognized, a PDPH diagnosis is simple to make; however, roughly one in every 3 PDPH is
diagnosed following an unrecognized dural puncture.3 PDPH is categorized by the International
Classification of Headache Disorders criteria as a headache occurring within 5 days of a dural
puncture, which has an orthostatic component and is associated with nausea, neck stiffness,
photophobia, or tinnitus.6 The cause of the PDPH is suggested to be a leak of cerebrospinal fluid
(CSF) through a hole in the dura; the low volume of CSF leads to intracranial hypotension and
structures sagging into the foramen magnum, as evidenced by radiological studies.3 While not
fatal, a PDPH can severely worsen a patient’s quality of life and lead to increased length of stay
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in the hospital, ultimately causing increased costs and decreased patient satisfaction.7 The most
commonly used treatment for PDPH is the EBP; while effective, the EBP is an invasive
procedure that can cause complications ranging from back pain to cauda equina syndrome.9
Scope of the Problem
Narrowing down the exact numbers of the incidence of PDPH can be challenging. The
frequency of accidental dural puncture during epidural placement is estimated to be roughly
1.5%, with upwards of 80% of those patients who experienced an accidental dural puncture
developing a PDPH;2,8 alternatively, rates of PDPH following spinal anesthetic falls between
1.5% to 11.2% with rates varying based on needle design and size.3 One of the most extensive
US studies which looked at the instance of PDPH and neuraxial labor analgesia was performed
by Delgado and associates; the study looked at nearly 2 million insured parturients in locations
across the US over a seven-year period.5 Delgado and colleagues showed the probability of
PDPH following a vaginal delivery with neuraxial analgesia was roughly 0.58%, whereas a
cesarean delivery with and without prior neuraxial analgesia was 0.47% and 0.64%,
respectively.5 With approximately two million obstetric neuraxial anesthetics performed
annually, that equates to around 4,000 PDPHs plaguing new mothers yearly.
Consequences of the Problem
PDPH has a broad range of consequences for the patient and the healthcare system. Patients
with PDPH are more likely to have a delayed discharge from the hospital, causing an increased
length of stay; they are also more likely to have subsequent emergency room or hospital visits.5
Ultimately, these discharge delays and readmissions lead to increased healthcare costs for the
patient and the facility. If patients cannot be discharged in a timely manner, this can lead to
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delays in care within the obstetrics department. Moreover, a new mother who must care for her
newborn child in the immediate postpartum period will significantly suffer from the side effects
of a PDPH; she may be unable to perform her activities of daily living and unable to provide care
for her child.1 Finally, PDPH is one of the most frequent causes of malpractice claims against
anesthesia providers.5
As far as EBPs go, treatment with EBP is given to more than 50% of patients who suffer
from PDPH, with approximately 1 in 10 of those receiving an EBP requiring a second EBP
treatment.5 Each additional EBP is a procedure with its own cost to the patient and the healthcare
facility. As previously stated, there are numerous risks to even performing an EBP.
Complications occurring following an EBP include arachnoiditis, meningitis, spinal hematoma,
repeat dural puncture, acute/chronic back pain, bradycardia secondary to increased intracranial
pressure, or infection.4
Knowledge Gaps
One of the most frequently cited studies comparing the SPGB to the EBP is a
retrospective study by Cohen et al.9 Cohen and colleagues evaluated a 17-year period at a single
institution and compared the outcomes and complication rates of the patients who received the
SPGB versus those who received the EBP; the results of the study indicated that more patients
had faster relief of their symptoms without any additional complications when SPGB was the
intervention.9 Similarly, a study by Youssef and associates executed a randomized clinical trial
to assess the effectiveness of SPGB versus Greater Occipital Nerve Block (GONB) in PDPH
patients following spinal anesthesia; this study found that the less invasive SPGB had similar
efficacy with no adverse effects.10 In addition to these larger-scale studies, numerous case
studies indicate the efficacy of SPGBs as PDPH therapy.3
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Russell and colleagues published a two-part series on the management of PDPH;
additionally, a recent comprehensive update was published in 2020 on the management and
treatment of PDPH by Patel and associates.3,11 Both of these practice updates list SPGB as
optional therapy for the management of PDPHs.3,11 However, providers are not using this
therapy as an option for patients. Delgado et al. showed that the EBP is primarily utilized as the
treatment for PDPH, with 60-70% of postpartum PDPH patients receiving an EBP.5 Since most
of the literature is targeted at the use of the EBP as a definitive treatment for severe PDPH, it can
be presumed that the lack of use of SPGB as a primary intervention is due to the provider’s lack
of knowledge on the treatment.
Proposal Solution
The SPGB has been suggested as a therapy for many pain disorders.12 SPGB can be
performed through 3 different approaches with varying advantages and disadvantages; it can be
performed via a transnasal topical or injection approach, a transoral approach, or an
infrazygomatic approach.12 The transnasal technique is the least invasive, has the lowest risk and
can be implemented bedside without any additional imaging equipment.13 Transnasal SPGBs
have fewer instances of complications, and even when complications occur, they are minor;
some minor complications include epistaxis, numbness, or decreased sensation of the nose,
palate, and pharynx or eye tearing.12 When compared with the efficacy of an EBP and time to
relieve PDPH symptoms, SPGBs have quicker symptom relief and similar long-term pain
alleviation.9 Since SPGBs have already been indicated for the treatment of other various
syndromes, have demonstrated effectiveness in the treatment of PDPH, and have fewer
complications than an EBP, they should become a more utilized alternative in the obstetric
anesthetists’ treatment repertoire.9,13 Implementation of an educational module will increase
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obstetric anesthesia providers' knowledge and improve attitudes toward using topical transnasal
SPGBs for the treatment of PDPH.
Additional Background
One frequent, severe complication following a dural puncture is post-dural puncture
headache (PDPH).14 PDPH may occur following a spinal anesthetic, an accidental dural puncture
during an epidural anesthetic, a therapeutic or diagnostic lumbar puncture, or the administration
of intrathecal medications.14-18 A PDPH can be classified by specific criteria; the International
Classification of Headache Disorders certifies a PDPH happens within five days of a dural
puncture and is associated with symptoms of photophobia, neck stiffness, nausea, and has an
orthostatic component.1,2
Following neuraxial procedures, the frequency of PDPH ranges from 6 to 36%; PDPH
can delay patient discharge, increase morbidity and lead to higher readmission rates.11 Initial
treatment for PDPH may be conservative, consisting of intravenous (IV) hydration, bed rest, and
caffeine; however, if this is unsuccessful, the epidural blood patch (EBP) is considered the most
successful therapy.2,11 The EBP is an invasive therapy that carries risks ranging from back pain
to cauda equina syndrome.11
One non-invasive, low-risk intervention which causes minimal adverse effects is the
sphenopalatine ganglion block (SPGB).18 There are three SPGB approaches transnasal, transoral,
and transcutaneous; the transnasal topical approach is the simplest technique and can be
performed bedside in the shortest amount of time with the lowest complication risk.13 The SPGB
has been found to have faster relief onset and fewer complications than the EBP and can be used
as a treatment alternative to conservative PDPH management.9

Page 11 of 72

Rationale
Regardless of proper technique and prevention practices, accidental dural punctures and
PDPH are infrequent but inevitable complications of neuraxial procedures; as such, anesthesia
providers should be aware of the various treatment options available.2 PDPH therapy has been
widely studied, and numerous treatment options have been used effectively.11 Pain from PDPH
is speculated to be because of a cerebrospinal fluid leak greater than the production rate.12 The
sphenopalatine ganglion is the biggest and most upper ganglion of the sensory, parasympathetic,
and sympathetic nervous system; secondary to its accessibility, this ganglion has been used to
treat multiple facial and head pain syndromes.12 The SPGB is believed to work by obstructing
the parasympathetic flow to the brain's vasculature; this allows the blood vessels to constrict to
a standard diameter and relieves the headache.12 SPGB has demonstrated success as a PDPH
treatment in numerous case studies and can be advantageous in patients who have
contraindications for an EBP.15,19-24
PDPH leads to decreased patient satisfaction, increased length of stay, and increased
readmission rates.7 The current definite treatment for PDPH is the EBP.2 However, an EBP may
be contraindicated in patients who have an infection at the site, are on an anticoagulant, or are
coagulopathic; furthermore, complications from an EBP can be severe and include meningitis,
intrathecal hematoma, abscess, or nerve palsies.11 If effective, the SPGB could be another
treatment option added to the PDPH treatment algorithm.
Objective
This literature review intends to examine and synthesize studies centered on the success
of SPGB as an alternative treatment for PDPH. As much of the current research studies center
on SPGB as a substitute for conservative treatment, the review focuses on SPGB as an
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intervention compared with conservative treatment or as an adjunct treatment when
conservative treatment is unsuccessful. The goal of the review is to present the material in a
way that allows anesthesia providers to assess SPGB's efficacy and improves providers'
knowledge and attitudes toward its use in the treatment of PDPH.
Methodology of Literature Review
Eligibility Criteria
Health science peer-reviewed journals were evaluated for this literature review; specific
inclusion and exclusion criteria were utilized to select those studies that best ascertained the
review's objectives. Studies printed within the previous five years, published in English, and
with complete article accessibility were included. Those studies where patients were less than
18 years of age, had a small sample size, or were published in other languages without total
article translation were excluded. Publications chosen included both obstetric and non-obstetric
patients suffering from PDPH and focused on transnasal SPGBs. Florida International
University’s (FIU) library service was employed to access the research studies through medical
journal databases.
Keywords were chosen based on the clinical question, and the subsequent search used the
applicable search symbols and Boolean operators: Postdural Puncture Headache,
Sphenopalatine Ganglion Block.
Information Sources
The two databases used for the search were MEDLINE (ProQuest) and The Cumulative
Index to Nursing and Allied Health Literature (CINAHL).
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Search Strategy
Significant search terms were extended to incorporate: (Postdural Puncture Headache OR
Post-dural Puncture Headache OR Post Dural Puncture Headache OR PDPH OR Post lumbarpuncture headache OR Spinal Headache) AND (Sphenopalatine Ganglion Block OR SPGB).
The preliminary search yielded 227 articles. CINAHL generated 213 reports, and MEDLINE
yielded 14 articles. All the articles in the MEDLINE search were also found in the CINAHL
search. Only studies circulated within the past five years, printed in English, and peer-reviewed
were incorporated to guarantee the most relevant and most recent studies were examined. This
elimination yielded 4 for MEDLINE and 50 articles for CINAHL. Additional duplicate articles
were eliminated, resulting in 36 studies that required supplementary evaluation. Titles were
rejected if they failed to meet inclusion criteria. For instance, studies that included broad PDPH
treatment updates or evaluated different methods of SPGBs were eliminated.
Twenty-eight studies were assessed and accepted for a complete abstract review. Eleven
of those studies were examined through comprehensive text analysis. The studies eliminated
consisted of small case studies consisting of 1 to 5 patients; the five studies selected for review
had larger sample sizes ranging from 20 to 60 participants.
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Sphenopalatine Ganglion Block
OR
SPGB

AND
Postdural Puncture Headache
OR
Post-dural Puncture Headache
OR
PDPH
OR
Post Lumbar-puncture Headache
OR
Spinal Headache

Diagram 1. Search Keywords

Results of Literature Review
Study Characteristics
The five articles selected for this literature review explored the use of the sphenopalatine
ganglion block and its efficacy in treating PDPH. The studies by Puthenveetitil et al., Yilmaz et
al., and Kumar et al. compared the SPGB to conservative treatment; in contrast, the studies by
Takmaz et al., and Khawaja et al., evaluated the patient response before and after the SPGB as a
treatment intervention.14-19 The research performed by Kumar and associates was further
subdivided into comparison groups that evaluated the efficacy of two different local anesthetic
concentrations.17 The reports performed by Takmaz and colleagues and Kumar and associates
also assessed patient satisfaction as an additional measurement of treatment efficacy.14,17
The three studies by Yilmaz et al., Puthenveetitil et al., and Kumar et al. were all
prospective.14,17,18 Yilmaz et al., and Kumar et al. utilized randomized selection while
Puthenveetitil et al. performed their study as an observational study.15,17,18 Khawaja and
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colleagues conducted their research as a large case series, while Takmaz and associates used a
retrospective approach to their analysis.14,16
Results of individual studies
Yilmaz and colleagues compared conservative treatment to conservative treatment with
the addition of the SPGB.15,18 The study by Yilmaz et al. was conducted as an experimental,
prospective, randomized controlled trial (RCT) and is considered Level I evidence.15, 25 Yilmaz
and associates enrolled 20 women diagnosed with PDPH following cesarean delivery with spinal
anesthesia.15 The conservative management group received 200mg of IV theophylline, 1 liter of
0.9% normal saline, 1g of acetaminophen every 6 hours, and 1500mg of magnesium sulfate; the
intervention group received a unilateral SPGB with 2cc of 10% lidocaine situated in the nose for
15 minutes.15 Pain assessments were completed at 4, 12, and 24-hour intervals using the visual
analogue scale (VAS); despite higher initial pain scores, participants in the intervention group
had a more significant reduction in pain by the first assessment interval and had lower pain
scores through the study completion.15
Yilmaz and associates concluded that while the pain scores were lower in the intervention
group, the differences in pain scores between the two groups were not statistically significant;
however, since the p-value (p=0.089) was approaching the significance limit (p<0.05), the
authors believed that the difference is more noteworthy than reported.15 The lack of significance
in the results was attributed to the study’s small sample size.15 One complication the authors
noted in a solitary participant; the participant suffered a single tonic-clonic seizure 2 hours after
treatment with an SPGB, which was caused by cerebral edema as evidenced by post-seizure
magnetic resonance imaging. The authors acknowledge the small sample size, the lack of control
group receiving a simulated SPGB with a plain cotton-tipped applicator, and the fact that neither
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the physicians nor participants were blinded were limitations of the study.15 Overall, Yilmaz and
colleagues established SPGB is a fast and efficient treatment for PDPH but suggested that further
clinical trials be performed.15
Kumar and colleagues compared conservative medical management to SPGBs performed
using 4% lidocaine and 10%to treatreatment of PDPH; similar to the study by Yilmaz and
associates, this study is considered Level I evidence because it was performed as an
experimental, prospective, randomized, observational study.17, 25 Twenty participants were
placed into the control group and received oral tramadol 37.5mg and acetaminophen 325mg
twice a day, caffeine 300-500mg daily, and were directed to rest in bed and increase fluid
intake.17 The first intervention group of 20 participants received a bilateral SPGB with a cottontipped applicator soaked in 1.5cc of 4% lidocaine for 10 minutes while the second intervention
group, also containing 20 participants, received two puffs of 10% lidocaine intranasally; pain
assessments using the VAS were performed at timed intervals beginning at 15 minutes and
increasing to every 24 hours until the patients were discharged.17 There was a noteworthy
decrease in VAS score following the SPGB in both intervention groups when compared to the
control group, and both intervention groups had 90% or greater of the participants ready for
discharge, defined by a VAS <3, at the 72-hour assessment compared to only 5% in the control
group.17 Kumar et al. determined SPGB is a cost-effective treatment for PDPH because it
decreases the length of hospital stay, as evidenced by the greater amount of patients ready for
discharge at 72 hours of treatment, with 10% lidocaine being slightly more effective than 4%
lidocaine at blocking the sphenopalatine ganglion.17
Similar to the studies by both Yilmaz et al. and Kumar et al., the research by
Puthenveetitil and associates assessed the application of SPGB as an alternative treatment option
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to conservative management for PDPH. Puthenveetitil et al study was a quantitative, quasiexperimental, prospective, unblinded, observational study classified as Level II evidence.18,25 At
the time of the study, the two obstetric consultants on staff at the facility treated PDPH with two
different methods: one used the sphenopalatine ganglion block, and the other used additional
conservative medical therapies.18 Puthenveetitil et al. enrolled 20 postoperative cesarean patients
who developed a PDPH within seven days of a subarachnoid block that was not alleviated with
conservative treatments of bed rest, intravenous fluids, caffeine, and abdominal binders; the
participants were not randomized, nor were they or the researchers blinded to the treatment the
participants were receiving.18 The conservative management group received 1g of
acetaminophen three times for a single day, if their pain was not adequately alleviated, 75 mg of
intravenous diclofenac (a non-steroidal anti-inflammatory drug) was added two times per day;
the intervention group was placed supine and received a SPGB with a 2%-lidocaine-soaked
cotton-tipped applicator situated anterior to the sphenopalatine ganglion for five minutes.18 Pain
levels for both groups were assessed at specific intervals from 30 minutes to 24 hours.18
Puthenveetitil et al. established a reduction of pain to a numeric score of less than four was
considered adequate.18 Since most of the patients in the SPGB group achieved a pain level of
zero, the authors used the median score of the intervention group to compare pain levels with the
mean score of the conservative management group.18 The conservative management group's
mean pain score gradually decreased to a level below four at the 4-hour interval and remained
there until the termination of the study; in contrast, the SPGB group's median pain score was
immediately reduced to less than four at the initial 30 minute assessment period and stayed
below 4 to the conclusion of the study as well.18 Puthenveetitil and associates acknowledge the
study was limited because it was not randomized not blinded; since it was an observational

Page 18 of 72

study, it was not registered with the Clinical Trial Registry.18 The onset of pain relief was
significantly reduced in the SPGB intervention group; as such, Puthenveetitil et al recommend
that the SPGB be used as an early treatment for PDPH and suggest that it can control severe
pain.18
The research performed by Takmaz and associates evaluated the efficacy of the SPGB as
a treatment for PDPH and the resulting patient satisfaction; similar to the study by Kumar et al.,
the participants were non-obstetric patients.14 The analysis was performed as a retrospective,
quasi-experimental study and is considered Level II evidence.14, 25 Twenty-six participants were
recruited into the study after being diagnosed with PDPH, and all received a bilateral SPGB with
2% lidocaine-soaked cotton-tipped applicators placed for a duration of 15 minutes; pain
assessments were performed using the VAS at intervals from 15 minutes to 48 hours post
block.14 Additionally, at 48 hours post block, patient satisfaction was evaluated using the Patient
Global Impression of Change (PGIC) scale.14 Takmaz and colleagues reported all participants
achieved adequate analgesia, which they defined as a VAS score <3, within 24 hours of the
procedure, with more than 90% of participants achieving that result at the initial 15-minute
assessment; furthermore, 100% of the participants rated their satisfaction as either "much
improved" or "very much improved," the two highest degrees of improvement on the PGIC
scale.14 Takmaz et al. concluded that PDPH unresponsive to conservative treatments could be
treated effectively with a SPGB and that the SPGB would be a reasonable treatment to consider
before treatment with an EBP.14
Khawaja and colleagues assessed the efficacy of the SPGB in the treatment of PDPH.
However, the authors performed a descriptive, cross-sectional case series; this study is deemed
non-experimental and is considered Level III evidence.16,25 The researchers gathered 53
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participants suffering from PDPH with VAS scores ranging from 7-10 and performed an SPGB
with 3-5cc of 1% lidocaine sprayed intranasally and kept the patients positioned supine for 2
minutes following the procedure; the pain was assessed before the block and 2 minutes after the
block using the VAS.16 Participants in the case series reported a significant decrease in pain
following the SPGB; the mean VAS dropped from 9.377 to 1.175, a reduction of 73% in the first
5 minutes following the block.15 By performing a paired t-test, the p-value<0.001 was deemed
significant and supported the reduction in pain following the SPGB; intrinsically, the authors
concluded that the SPGB is a reasonable treatment selection for PDPH.15
Discussion
Postdural Puncture Headache (PDPH) is a severe complication following accidental or
intentional dural puncture during various neuraxial procedures.14 The current gold standard
treatment is the epidural blood patch (EBP); however, the therapy can cause adverse effects from
bleeding to infection and even paralysis.14, 18 The sphenopalatine ganglion is a nervous system
structure with direct access to the outside environment through the nasal cavity; it encompasses
somatic sensory roots and parasympathetic and sympathetic components located in the
pterygopalatine fossa.14,16 The sphenopalatine ganglion block (SPGB) is a simple procedure that
has been shown to provide relief in treating many headaches and neuralgic pain syndromes.18
The above literature review sought to collect recent and relevant studies regarding the use of
SPGB for treating PDPH.
Yilmaz et al. demonstrated a unilateral SPGB as an effective treatment for a rapid
reduction in pain caused by a PDPH; this was evidenced by the significant decrease in VAS pain
score at the 4-hour interval following the SPGB.15 Furthermore, Yilmaz et al. discussed that a
larger sample size might contribute to significant decreases in VAS pain scores following SPGB
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for the other interval periods in future studies.15 The most extensive study evaluated, performed
by Kumar et al., also showed a significant reduction in pain and increased readiness for
discharge amongst patients who received the SPGB.17 Puthenveetitil et al. also had a promising
decrease in pain scores for nearly 90% of their study participants within 5 minutes of receiving
the SPGB; moreover, most of the SPGB group participants reported a pain level of zero.18
Takmaz et al. reported a rapid reduction in headache pain within 15 minutes of the
SPGB, and the entire intervention group had attained adequate analgesia within 24 hours of the
procedure; additionally, the patient satisfaction with this procedure was very high.14 Finally,
Khawaja et al. reported a significant reduction in PDPH pain within 5 minutes of the block.16
Conclusion
PDPH can be an unavoidable complication arising from neuraxial procedures, and as
such, providers should be up to date on the treatment options for their patients. The first-line
treatment for PDPH is conservative medical management, and the definitive therapy is the
epidural blood patch; however, other alternatives may be equally as effective as the EBP with as
few side effects as conservative management. The sphenopalatine block is a safe, effective
treatment for PDPH; it is inexpensive, easy to perform at the patient’s bedside, and requires
limited tools and equipment.
Current evidence-based research focusing on SPGB for the treatment of PDPH was
reviewed. The goal of the review was to establish evidence of the efficacy of the SPGB. The
information in the five studies will create the foundation of a quality improvement (QI) project
which centers on educating anesthesia providers on the use of the SPGB in the treatment of
PDPH. By utilizing the most recent evidence-based research, the QI project is anticipated to
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improve anesthesia providers' knowledge and attitudes toward using sphenopalatine ganglion
block either as an adjunct or independent therapy for the treatment of PDPH.
Purpose/ PICO Clinical Questions/Objectives
PICO Question or Purpose
Population (P): Anesthesia providers
Intervention (I): Sphenopalatine Ganglion Block Education
Comparison (C): No education
Outcomes (O): Improve provider attitudes and knowledge toward the use of
Sphenopalatine Ganglion Block
Primary DNP Project Goal
One common complication of neuraxial procedures is post-dural puncture headache
(PDPH).11 The hallmark of PDPH diagnosis is a headache arising within five days of a
neuraxial procedure that is exacerbated when sitting or standing and alleviated when lying
supine.17 PDPH is caused by a disproportionate deficit of cerebrospinal fluid (CSF) production
to CSF loss which causes intrathecal hypotension.15 Conservative management with hydration,
bed rest, oral analgesics, and caffeine is the initial therapy for PDPH; however, if conservative
treatment fails, the epidural blood patch (EBP) is considered the most effective treatment.14,15
EBP is an invasive procedure with risks ranging from an additional inadvertent dural puncture
to infection and neurological complications.17 As a result of the invasiveness and dangers of the
EBP, PDPH treatment alternatives have been studied extensively.11
The sphenopalatine ganglion is found in the pterygopalatine fossa. It possesses somatic
sensory, parasympathetic, and sympathetic roots; through this ganglion, the Sphenopalatine
ganglion block (SPGB) works by blocking the parasympathetic outflow to cerebral vessels.17
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The SPGB has been previously used to treat various types of headaches and neuralgic pain
syndromes.14 Numerous case studies have shown success with using the SPGB to treat PDPH; it
can also be a vital treatment option for those patients who have contraindications to EBP.15,19-24
Furthermore, multiple more extensive studies proved that the SPGB provides a rapid decrease in
pain caused by PDPH, improves readiness for discharge, and increases patient satisfaction.14-18
The prevalence of PDPH after neuraxial procedures ranges from 6 to 36% and can also
be found following procedures performed for pain management; PDPH is most commonly seen
following neuraxial procedures performed for surgery, secondary only to its occurrence in
obstetrics anesthesia.11 Since PDPH is an inevitable complication, anesthesia providers should
be knowledgeable of current treatment modalities.2 The main objective of developing the SPGB
educational module is to enhance the knowledge of the anesthesia provider on the use of the
SPGB. Ideally, by increasing providers' knowledge and familiarity with the block, the
educational module will improve their attitude toward using the block in treating PDPH.
Goals and Outcomes
The SMART format was utilized in developing the target objectives; the SMART format
indicates that objectives ought to be specific, measurable, achievable, realistic, and timely.26
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Specific
Anesthesia providers will receive an evidence-based educational module highlighting the
use of the SPGB in the treatment of PDPH.
Measurable
The success of the educational intervention will be assessed through the analysis of a
survey administered to the participants as a pre and post-test surrounding the academic module.
Outcomes will be evaluated by appraising the changes in the anesthesia providers’ knowledge
and attitudes towards PDPH, current standard PDPH treatments, SPGB, and the use of SPGB as
a treatment for PDPH. Qualtrics® software will be utilized to generate the surveys and analyze
the records.
Achievable
With the assistance of DNP Preceptor Lisa Mills, CRNA, ARNP, and DNP Advisor Jorge
Valdes, DNP, CRNA, APRN, an online educational module will be created that highlights the
research, benefits, and efficacy of the SPGB.
Realistic
Anesthesia providers will be educated on the SPGB via an online educational module.
The online module creates an easily accessible format that can reach providers on all shifts at
their leisure.
Timely
The “Educating Anesthesia Providers on Sphenopalatine Ganglion Block as Post Dural
Puncture Headache Treatment” educational module will be finalized and presented to anesthesia
providers within a 6-month time frame. The results from this education will be available after
the 9-month project; the timeline of the project is as follows: within 6 months the educational
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module will be developed, the educational module will then be available for 60 days for
providers to access and build competency, after the module closes, within 30 days the data will
be analyzed and synthesized to show the results of the knowledge questionnaire.
Program Structure
Creating the SPGB for PDPH treatment educational module will necessitate a concerted
effort from providers and educators. A thorough analysis will be executed to assess the
significance and value of the project and how it will benefit the organization and the providers;
this will emphasize the differences in the current state of practice versus what the future state of
practice at this facility can be.26 Utilizing the SWOT assessment tool, an evaluation of the
project’s strengths, weaknesses, opportunities, and threats will be completed.26
This program intends to establish the providers’ understanding of the current clinical
practice and the use of the SPGB in the treatment of PDPH. At the start of the project, a panel of
professionals will be identified to direct the development of the learning module. Participants
will initially be given a survey to evaluate their understanding of post-dural puncture headaches,
treatment options, and sphenopalatine ganglion blocks. An educational course will then be
electronically distributed focusing on PDPH, its prevalence, the SPGB as an alternate treatment,
and its efficacy and benefits. Following the educational intervention, the participants will be
provided with a survey to assess the changes in their knowledge and attitudes toward SPGB
following the educational module.
Strengths
In the SWOT analysis, strengths are the internal characteristics of the intervention that
are beneficial to the plan.26 The transnasal sphenopalatine ganglion block (SPGB) is a reliable
and favorable treatment for PDPH.11 The technique has low risks and is minimally invasive.11
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The ease of application of the SPGB is the greatest strength of the block; it can be done bedside
with local anesthetic and cotton-tipped applicators.15 The educational module will be an online
module that facilitates provider accessibility. The facility where the intervention will be
implemented advertises research and innovation as a benefit to its patients; the research and
education of the module align with the organization's vision. These strengths benefit the
implementation of the project.
Weakness
Weaknesses of the intervention consist of any internal attributes that could be destructive
to the intervention.26 The number of controlled studies for SPGB is limited, so it has yet to be
promoted as a definitive treatment for PDPH.13 Some contraindications to the block include
allergy to local anesthetic, infection, patient refusal, facial trauma history, and anticoagulation
therapy.13 Minor complications from SPGB include epistaxis, palate, pharynx, and nose
numbness, and eye tearing.13 Furthermore, the educational module will be distributed via email
to anesthesia providers at the facility; since participation is entirely voluntary, providers may not
participate or view the information included in the course. These drawbacks may weaken the
acceptance of the SPGB as a therapy for PDPH and interfere with the execution of the
intervention.
Opportunities
Opportunities, in contrast, are any future external opportunities that may benefit the
program.26 The SPGB is commonly performed by neurologists and pain management specialists
for chronic pain syndromes; as a result, it is a treatment option that anesthesia providers may not
be familiar with.13 This educational module is the opportunity to expand providers’ knowledge of
the block and its application to use in PDPH. The organization has four other facilities within the
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hospital system; if the educational intervention performs well at the initial facility, it is possible
to distribute the material to the other facilities to expand its reach. These opportunities may
promote the potential of the project.
Threats
Threats are external considerations that may damage the plan or obstruct the
intervention’s capacity to accomplish its objectives.26 Providers may have a standard protocol
that they follow for PDPH; as a result, they may have opinions about what has worked for them
and be unwilling to change their practice. Additionally, the small sample size of the RCTs in the
literature and the single patient who suffered a seizure may be enough to dissuade practitioners
from utilizing the SPGB. These factors may impede the success of the project.
Organizational factors
Implementation of the “Educating Anesthesia Providers on Sphenopalatine Ganglion
Block as Post Dural Puncture Headache Treatment” learning module will be achieved through a
multi-step collaborative approach. Initially, the steps to develop the program will be established.
Goals will be created to assess the efficacy of the intervention. During the evaluation, the
overall effectiveness of the module will be appraised. After the intervention, the team will be
required to deliver a synopsis of outcomes. The overview will be understandable and consist of
the program narrative, interventions, purpose statement, data collection methods, and data
analysis; it will include background on the clinical issue, collection tools, findings, conclusions,
outcomes, limitations, and recommendations for the program improvement.
Definitions and Outcomes
The main outcome that was assessed was the relief of Post-dural Puncture Headache
(PDPH) symptoms. The intervention that was evaluated was the Sphenopalatine Ganglion Block
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(SPGB). A numeric pain rating score was used by Puthenveettil, et al., while the Visual Analog
Score (VAS) was utilized in the remaining studies.14-18
Post-dural Puncture Headache (PDPH). Kumar et al. recognizes PDPH by the International
Classification of Headache Disorders definition which describes a headache arising within 5 days
following a subarachnoid block that is exacerbated when seated or standing and alleviated when
lying supine.17 The headache may be associated with tinnitus, photophobia, neck stiffness,
hypoacusia, and neck stiffness.2
Sphenopalatine Ganglion (SPG). The Sphenopalatine Ganglion is a parasympathetic ganglion \
situated outside the cranium; it is positioned within the pterygopalatine fossa.13 The SPG has
both autonomic and sensory innervation.13 The parasympathetic terminates in the SPG where
second-order neurons deliver a secretomotor function to lacrimal glands, mucous membranes,
and offshoots to the cerebral and meningeal blood vessels.13
Sphenopalatine Ganglion Block (SPGB). SPGB can be accomplished by three approaches:
transcutaneous, transoral, or transnasal.13 All of the studies evaluated employed the transnasal
SPGB as the intervention of choice because it is the simplest technique with low risk and a short
procedure time.13-18 Cotton-tipped applicators soaked with varying concentrations of lidocaine
were utilized in four of the studies evaluated.14-15, 17-18 The study by Khawaja et al., and one
intervention group from the study performed by Kumar et al. sprayed lidocaine intranasally.16,17
Numeric rating scale (NRS). Puthenveettil, et al. assessed the presence of pain for its
participants using the numeric pain score.18 The scale ranges from zero to ten, with ten being the
worst possible pain imaginable, and zero being no pain.18 Assessments were performed at
predefined intervals following the intervention (at 30 minutes, 1, 2, 4, 6, 8, 12 and 24 hours post
intervention).18
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Visual Analog Score (VAS). The remaining studies used the visual analog scale to rate
participants’ pain.14-17 Khawaja et al. quantified the VAS from 0-10, with 0 equating to “no pain
at all” and 10 equating to “severe pain.”16 Pain assessments were performed using the VAS at
varying intervals. Takmaz et al. performed assessments at 15 minutes, 30 minutes, 24 hours, and
48 hours.14 Similarly, Kumar and colleagues executed assessments for 15 minutes, 30 minutes, 1
hour, 2 hours, and every 24 hours until the participants were discharged.17 Khawaja et al.
performed the assessment before and after the block; while Yilmaz and associates performed the
assessment at 4, 12, and 24 hours post intervention.15,16
Methodology of Quality Improvement
Setting
The setting for this DNP project is Memorial Regional Hospital (MRH), a 797-bed
hospital in Hollywood, Florida.27 MRH is “the flagship facility of [Memorial] healthcare system
and is one of the largest hospitals in Florida.” 27 Anesthesia services are provided by certified
registered nurse anesthetists (CRNAs), anesthesia assistants (AAs), and anesthesiologists in 26
anesthesia delivery locations, including the main operating room (OR), interventional radiology
laboratories, cardiac catheterization laboratories, obstetrics, and more.27
Recruitment and Participants
To effectively accomplish the objectives of this quality improvement project, a series of
activities will be performed that require a specific group of study participants to receive an
educational intervention on SPGB and its use in the treatment of PDPH. Primary participants
include anesthesia providers employed by Envision Physician Services who primarily practice at
MRH. Participation will be voluntary, and the sample size is anticipated to be between 10-15
participants.
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Following the receipt of approval from the Institutional Review Boards (IRB), email
addresses will be acquired for MRH CRNAs, AAs and anesthesiologists. To safeguard the
anonymity of the participants, the emails will be kept confidential. An email invite containing the
pre-test, educational module, and post-test will be delivered to participating staff. Participation in
the quality improvement project is entirely voluntary, and the target population can drop out at
any time, for any reason.
Intervention and Procedures
To reduce gaps in provider knowledge and improve the quality of patient care received, it
is crucial for providers to receive continuing education. The educational intervention is designed
to expand anesthesia providers' knowledge about the use of the SPGB as a treatment alternative
for PDPH. An email invite to the learning intervention will be delivered to the anesthesia staff at
MRH. An online pre-test survey will be administered to participants to assess their existing
knowledge and perceptions of PDPHs and current treatment options. Following this pre-test, a
ten-minute educational module will be delivered discussing SPGB and its use in the management
of PDPH. The educational module will be delivered in the form of a voiceover PowerPoint
which permits the participant to either listen to the speaker or read through the PowerPoint
depending on individual learning style. The presentation will inform participants of the
background and physiology of PDPH as well as the SPGB, current treatments for PDPH, and the
prospect of using the SPGB as a treatment alternative for PDPH. After the educational
intervention, a post-test survey will be given to assess any learning that was accomplished as a
result of the educational module.
Data acquired from the post-test survey will offer insight into the effectiveness of the
educational module. Results from the survey will also assist in guiding the intra-facility
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expansion of the use of the SPGB for treating PDPH. Outcomes from the survey will assess if
additional education is necessary and if the program would benefit other providers throughout
the hospital system or the anesthesia physician group.
Protection of Human Subjects
No individual identifiers will be employed when gathering or storing data, and no
medical record data will be extracted for use in this project. All participants will remain
anonymous for the entirety of the QI project to safeguard the rights and confidentiality of those
involved. Data collected will be kept in a secure, password-protected computer.
Data Collection
Qualtrics software will be utilized to collect participant demographics and data from the
pre and post-tests. Before the pre-test, participants will be asked questions to gather demographic
information. The pre-test will include ten multiple-choice questions designed to establish
knowledge of PDPH, current treatments, SPGB, and its use in the treatment of PDPH. A single
attitude-based question will be incorporated to determine if practitioners will consider using
SPGB in their practice. The post-test survey will contain an identical set of the 11 questions to
quantify the extent of learning that occurred, and if a practice change is feasible. Both pre and
post-test survey questions will be structured as multiple-choice or true/false.
Data Management and Analysis Plan
The DNP student will be the co-investigator responsible for administering the survey for
this project. The Participants will be provided two weeks to carry out the surveys and educational
module via the link included in the email. Excel software will be utilized to assess pre and posttest replies; this will show if participant knowledge was increased and if there is a potential
modification in participant practice because of the educational module. All replies will be
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transferred from Qualtrics to Excel software to evaluate the statistical comparison between pre
and post-test responses; the educational intervention efficacy and its impact on clinical practice
will be assessed through statistical analysis. This breakdown will help establish practitioner
assessments of the intervention and if learning transpired.
Discussion of Results
At the end of the data collection, the results will be analyzed. Conclusions can be drawn
from the comparisons made between the pre-test questionnaires and the post-test questionnaires.
The comparisons will show if significant learning has occurred and if providers are more likely
to consider using SPGB for the treatment of PDPH.
Quality Improvement Project Results
Demographics
A total of 47 invitations were distributed via email to Envision Anesthesia providers
employed at Memorial Regional Hospital. Seven participants consented to participate and
completed the educational intervention, including the pre-and post-test. The demographics of
those who participated are as follows: male (n = 3, 43%), female (n = 4, 57%), age in years 2535 (n = 3, 43%), age 36-45 (n =1, 14%), age 46-55 (n =3, 43%), Hispanic (n = 1, 14%),
Caucasian (n = 3, 43%), African American (n =2, 29%), and other (n = 1, 14%). All participants
were certified registered nurse anesthesthetists (n = 7, 100%), with either a Master’s degree (n =
1, 14%), or Doctorate (n = 6, 86%), and 1-2 years experience (n = 3, 43%), 2-5 years experience
(n=1, 14%) or >10 years experience (n = 3, 43%) as an anesthesia provider.

The demographics of the participants surveyed are represented below.
Table 1. Participant Demographics
Demographics

N (%)
Page 32 of 72

Total Participants

7(100%)

Gender
Male
Female
Non-binary/third gender
Prefer not to say

3 (43%)
4 (57%)
0 (0%)
0 (0%)

Age
25 - 35 yr
36 - 45 yr
46 - 55 yr

3 (43%)
1 (14%)
3 (43%)

56 - 65 yr

0 (0%)

> 65 yr

0 (0%)

Ethnicity
Hispanic
Caucasian
African American
Asian/Pacific-Islander
Other

1 (14%)
3 (43%)
2 (29%)
0 (0%)
1 (10%)

Position/Title
CRNA
MD Anesthesia
Other Anesthesia

7 (100%)
0 (0%)
0 (0%)

Education
Associate
Bachelor
Masters
Doctorate
Other

0 (0%)
0 (0%)
1 (14%)
6 (86%)
0 (0%)

Years of Practice
1 – 2 yr
2 – 5 yr
5 – 10 yr
> 10 yr

3 (43%)
1 (14%)
0 (0%)
3 (43%)
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Pre-test Knowledge of Sphenopalatine Ganglion Blocks for the Treatment of PDPH
The pre-test consisted of 12 questions that assessed providers’ knowledge of Postdural
Puncture Headaches (PDPHs), current treatment guidelines for PDPHs, and the use of
Sphenopalatine Ganglion Blocks (SPGBs) for the treatment of PDPHs. Most participants were
able to correctly identify the consequences of PDPHs, the mechanism of action of the SPGB, and
the ways in which the SPGB has been shown to improve the treatment of PDPH (n=5, 71.43%).
Slightly more than half of the participants (n=4, 57.14%) were able to correctly identify the
hallmark symptom, the current gold standard treatment, and the suspected causation of PDPH, as
well as the least invasive SPGB technique. Less than half of the participants (n=3, 42.86%) could
correctly identify the most common complication of neuraxial anesthesia, the location of the
sphenopalatine ganglion, and what the parasympathetic response of the sphenopalatine ganglion
causes.
Pre-test provider attitude questions resulted in varied responses. Regarding their
likelihood of using alternative methods for PDPH treatment, both “somewhat likely” and
“somewhat unlikely” received equal responses (n=3, 42.86%). In contrast, only one participant
(n=1, 14.29%) remained neutral and chose “neither likely nor unlikely”. Regarding their
likelihood to recommend the SPGB, most participants were neutral and chose “neither likely nor
unlikely” (n=3, 42.86%), some were more conservative and chose “somewhat unlikely” (n=2,
28.57%), and one participant each selected "most likely” and “somewhat likely” (n=1, 14.29%).
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Post-test Knowledge of Sphenopalatine Ganglion Blocks for the Treatment of PDPH
Participants completed a post-intervention questionnaire following the voiceover
PowerPoint educational intervention; this questionnaire consisted of the same questions
presented in the pre-test. The results assessed an increase in knowledge gained from the
educational intervention and are displayed below (Table 1). Nearly every question demonstrated
an increase in knowledge, as evidenced by an increase in the quantity of correct answers selected
when the post-test results were compared to those of the pre-test. The most significant increase
was noted on the questions which asked about the most common complication of neuraxial
anesthesia, the location of the sphenopalatine ganglion, and the suspected causation of a PDPH;
all three questions saw a 42.9% increase in participants (n=3) identifying these answers
correctly. The two questions regarding the pathophysiology of the sphenopalatine ganglion’s
sympathetic outflow and the current gold standard treatment for PDPH showed a 28.6% increase
in participants answering correctly (n=2). While the remaining four questions showed improved
results by 14.3% (n=1).
There was no change in the results of one question in the pre and post-test. This question
addressed which Sphenopalatine Ganglion Block technique was the least invasive. Four
participants of the seven answered this question correctly both before and after the educational
intervention.
When questions were posed regarding providers’ attitudes toward the utilization of SPGB
in the treatment of PDPH, significant increases were noted following the educational
intervention. The question was asked to participants regarding their likelihood to use alternative
methods for PDPH treatment; a positive score for this question was counted if providers
described themselves as “most likely” or “somewhat likely”. Prior to the educational
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intervention, zero participants described themselves as “most likely” (n=0, 0%), and 3
participants described themselves as “somewhat unlikely” (n=3, 42.86%) to use alternative
methods for PDPH treatment. However, after viewing the educational intervention, zero
participants described themselves as “somewhat unlikely” (n=0, 0%), and 3 participants
described themselves as “most likely” (n=3, 42.86%) to use alternative methods for PDPH
treatment. This demonstrates an increase in the likelihood of using alternative methods for PDPH
treatment by 42.9% (n=3).
Similarly, when the question was posed regarding the likelihood of providers
recommending the SPGB, the largest positive change was noted. A positive score for this
question was counted if providers described themselves as “most likely” or “somewhat likely” to
recommend SPGB. Prior to the educational intervention, 2 participants characterized themselves
as “somewhat unlikely” (n=2, 28.57%), and 3 participants characterized themselves as “neither
likely nor unlikely” (n=3, 42.86%) to recommend the SPGB. However, after completing the
educational intervention, an increase in “most likely” and “somewhat likely” responses was
noted. Four participants characterized themselves as “most likely” (n=4, 57.14%) 2 participants
described themselves as “somewhat likely” (n=2, 28.57%), and only one participant
characterized themself as “neither likely nor unlikely” (n=1, 14.29%) to recommend the SPGB.
This demonstrates an increase in the likelihood to recommend by nearly two-thirds of the
participants (n=4, 57.1%).
Table 2. Difference in Pre- and Post-Test Responses (Knowledge About PDPH & SPGB)
CORRECT RESPONSES
THE MOST COMMON COMPLICATION RESULTING
FROM NEURAXIAL ANESTHESIA IS:
CONSEQUENCES OF POSTDURAL PUNCTURE
HEADACHE (PDPH) INCLUDE:

PRE-TEST
(N=7)
3

POST-TEST
(N=7)
6

DIFFERENCE
(%)
42.9

5

6

14.3
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THE HALLMARK SYMPTOM OF A POSTDURAL
PUNCTURE HEADACHE (PDPH) IS:
THE SPHENOPALATINE GANGLION IS LOCATED IN
THE:

4

5

14.3

3

6

42.9

THE MAJOR PARASYMPATHETIC OUTFLOW OF THE
SPHENOPALATINE GANGLION CAUSES?
WHAT IS THE CURRENT GOLD STANDARD
TREATMENT OF POSTDURAL PUNCTURE HEADACHE
(PDPH)?
WHICH SPHENOPALATINE GANGLION BLOCK (SPGB)
TECHNIQUES IS THE LEAST INVASIVE:

3

5

28.6

4

6

28.6

4

4

0

4

7

42.9

5

6

14.3

5

6

14.3

POSTDURAL PUNCTURE HEADACHE (PDPH) IS
SUSPECTED TO RESULT FROM
SPHENOPALATINE GANGLION BLOCK (SPGB) WORKS
BY
SPHENOPALATINE GANGLION BLOCK (SPGB) HAS
BEEN SHOWN TO IMPROVE THE TREATMENT FOR
POSTDURAL PUNCTURE HEADACHE (PDPH) BY?

Table 3. Difference in Pre- and Post-Test Responses (Attitudes Toward PDPH & SPGB)
CORRECT RESPONSES
HOW LIKELY ARE YOU TO USE ALTERNATIVE
METHODS FOR POSTDURAL PUNCTURE HEADACHE
(PDPH) TREATMENT?
HOW LIKELY ARE YOU TO RECOMMEND
SPHENOPALATINE GANGLION BLOCK?

PRE-TEST
(N=7)
3

POST-TEST
(N=7)
6

DIFFERENCE
(%)
42.9

2

6

57.1

Summary of Data
Overall, the outcome of the educational intervention verified an increase in knowledge
between the pre-test and post-tests and an increase in the likelihood of participants using or
recommending the Sphenopalatine Ganglion Block (SPGB) for Postdural Puncture Headache
(PDPH) treatment. One exception was the ability to identify the least invasive technique for the
SPGB, as no change was noted between the pre and post-test results despite the educational
intervention. The graphs below show the change between the pre- and post-test answers for each
question.
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The most common complication resulting from neuraxial
anesthesia is:
7
6
5
4
3
2
1
0
Infection

Cerebral Hemorrhage
Pre-test

Postdural puncture
headache

Acute/chronic back pain

Post-test

Consequences of postdural puncture headache (PDPH)
include:
7
6
5
4
3
2
1
0
Malpractice
claims

Increased costs

Subsequent
hospital visits
Pre-test

Increased length Decreased patient All of the above
of stay
satisfaction
Post-test
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The hallmark symptom of a postdural puncture headache
(PDPH) is:
6
5
4
3
2
1
0
Nausea/vomiting

Photophobia

Postural Component

Pre-test

Dizziness

Post-test

The Sphenopalatine Ganglion is located in the:
7
6
5
4
3
2
1
0
Ischial tuberosity

Temporomandibular joint
Pre-test

Pterygopalatine fossa
Post-test
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Eustachian tube

The major parasympathetic outflow of the Sphenopalatine
Ganglion causes?
6
5
4
3
2
1
0
Vasoconstriction of the
cranial blood vessels

Vasodilation of the cranial Vasodilation of peripheral
Vasoconstriction of
blood vessels
blood vessels
peripheral blood vessels
Pre-test

Post-test

What is the current gold standard treatment of postdural
puncture headache (PDPH)?
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Greater Occipital Nerve Bed rest, caffeine, and oral
Block
analgesics
Pre-test

Acupuncture
Post-test
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Epidural Blood Patch

Which Sphenopalatine Ganglion Block (SPGB) techniques is
the least invasive:
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Transnasal topical

Transnasal injection
Pre-test

Transoral

Infrazygomatic

Post-test

Postdural puncture headache (PDPH) is suspected to result
from
8
7
6
5
4
3
2
1
0
Blood in the subarachnoid Intracranial hypotension
space
resulting from decreased
Cerebrospinal Fluid
Pre-test

Intracranial hemorrhage

Post-test
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An electrolyte imbalance

Sphenopalatine Ganglion Block (SPGB) works by
7
6
5
4
3
2
1
0
Numbing the brain

Blocking the
parasympathetic outflow
of the cerebral vasculature
Pre-test

Vasodilating the blood
vessels in the nose

Increasing production of
cerebrospinal fluid

Post-test

Sphenopalatine Ganglion Block (SPGB) has been shown to
improve the treatment for postdural puncture headache
(PDPH) by?
7
6
5
4
3
2
1
0
Decreased Visual Analog
Scale (VAS) pain scores

Improved patient
readiness for discharge
Pre-test

A significant decrease in
onset of pain relief
Post-test
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All of the above

How likely are you to use alternative methods for postdural
puncture headache (PDPH) treatment?
3.5
3
2.5
2
1.5
1
0.5
0
Most likely

Somewhat likely

Neither likely nor
unlikely
Pre-test

Somewhat unlikely

Most unlikely

Post-test

How likely are you to recommend Sphenopalatine Ganglion
Block?
4.5
4
3.5
3
2.5
2
1.5
1
0.5
0
Most likely

Somewhat likely

Neither likely nor
unlikely
Pre-test

Somewhat unlikely

Most unlikely

Post-test

Limitations
Several limitations were noted in this quality improvement project. The first limitation
was the small sample size. The survey was distributed to 47 email addresses, however, only 7
people chose to participate. To gain a more accurate picture of providers’ preexisting knowledge
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of Postdural Puncture Headaches (PDPHs), current treatment guidelines, and the utilization of
the Sphenopalatine Ganglion Block (SPGB) in the treatment of PDPH, a larger, more diverse
sample would be optimal. A larger sample size would also serve to solidify the findings of this
survey and demonstrate the effectiveness of the educational intervention.
The limited time frame of this survey may have contributed to the small sample size, as
participants were only given two weeks to respond to the email survey link. Perhaps a longer
time period would have allowed participants more time to respond to their invitation. Another
identified limitation to this project is that this survey was only distributed to participants at a
single facility. By distributing this survey to providers at multiple facilities/locations, a more
accurate representation of anesthesia providers’ knowledge and practices would be identified as
opposed to one facility’s culture or standard practice.
Future Implications for Advanced Nursing Practice
The Sphenopalatine Ganglion Block (SPGBs) has shown faster pain relief onset and
fewer complications than the EBP and can be employed as an effective treatment alternative to
conservative Postdural Puncture Headache (PDPH) management. Anesthesia providers should be
up to date on all available treatment options for their patients. With improved education on the
topic of SPGBs for the treatment of PDPHs, providers will have the knowledge and confidence
to select the appropriate treatment alternative for their patients. The results of this project are
significant in establishing approaches accessible to participants which will enhance knowledge
and possibly alter providers’ practice to improve patient outcomes. The data collected
demonstrates that the educational intervention successfully improved anesthesia provider
knowledge on the use of SPGB in the treatment of PDPH. Additionally, the conclusions drawn
from this project show that providers have an increased likelihood of using the SPGB in treating
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PDPH after viewing the educational intervention. The findings of this project can be applied to a
larger audience of anesthesia providers. As more research is performed on the efficacy of SPGB
in the treatment of PDPH, it will only serve to strengthen the evidence in the educational module
and encourage providers to utilize this lower-risk, effective treatment.
Conclusion
Postdural Puncture Headache (PDPH) is a potential adverse effect occurring from
neuraxial procedures with a frequency ranging from 6 to 36%; PDPH can increase morbidity,
postpone patient discharge, and lead to higher readmission rates. The epidural blood patch (EBP)
is thought to be the most effective therapy; however, it carries substantial risks. One noninvasive, low-risk intervention that produces negligible adverse effects is the sphenopalatine
ganglion block (SPGB). Without the knowledge of alternative therapies for PDPH management,
anesthesia providers may not be able to provide their patients with all their potential treatment
options. Through educational interventions like this quality improvement project, provider
knowledge and attitudes can be increased, which can lead to an increase in the likelihood of
utilization of SPGB over EBP for the treatment of PDPH. Ultimately, this can lead to improved
patient outcomes.
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Appendix B: QI Project Consent

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“An Educational Module for the Utilization of Sphenopalatine Ganglion Blocks as a Treatment
Alternative for Post Dural Puncture Headache: A Quality Improvement Project”

SUMMARY INFORMATION
Things you should know about this study:








Purpose: Educational module concerning use of Sphenopalatine Ganglion Block
(SPGB) for the treatment of Postdural Puncture Headache (PDPH)
Procedures: Participate in a pre-test, an Educational Module via voice over
PowerPoint, and then participate in a post-test
Duration: This will take about a total of 20 minutes.
Risks: The main risk or discomfort from this research is minimal
Benefits: The main benefit to you from this research is increase the participant’s
knowledge on the sphenopalatine ganglion block
Alternatives: There are no known alternatives available to you other than not taking
part in this study.
Participation: Taking part in this research project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE PROJECT
The goal of this project is to increase provider knowledge on the topic of Sphenopalatine
Ganglion Blocks (SPGBs) for the treatment of Postdural Puncture Headache (PDPH); the target
audience is certified registered nurse anesthetists (CRNAs). You are being asked to participate
in this quality improvement project
NUMBER OF STUDY PARTICIPANTS
If you decide to be in this study, you will be one of 10 people in this research study.
DURATION OF THE PROJECT
Your participation will require about 20 minutes of your time, you will be one of 10 people in
this study.
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PROCEDURES
If you agree to be in the project, we will ask you to do the following things: Participate in a pretest, view an Educational Module via voice over PowerPoint, and then participate in a post test.

RISKS AND/OR DISCOMFORTS
Minimal risk, risk not greater than if participant was conducting similar activity. Physical,
psychological, social, legal, and economic risks minimal and no greater than if a participant was
participating in a similar activity. Similar activity such as filling out an online survey and
watching voice over PowerPoint.

BENEFITS
The following benefits with your participation in this project: An increase in your knowledge
surrounding the pathophysiology of postdural puncture headaches (PDPHs) and sphenopalatine
ganglion blocks (SPGBs), current treatments for PDPHs and their pitfalls, as well as how
SPGBs can be used as an alternative treatment for PDPH.

ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project.
However, if you would like to receive the educational material given to the participants in this
project, it will be provided to you at no cost.

CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent
provided by law. If, in any sort of report, we might publish, we will not include any
information that will make it possible to identify you as a participant. Records will be stored
securely, and only the project team will have access to the records.

PARTICIPATION: Taking part in this research project is voluntary.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or for participating in
this project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
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will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent at such time that they feel it is in the best interest.

RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Jacquelyn O’Connor at 954-295-9699/jbrei001@fiu.edu or Dr.
Jorge Valdes at 305-348-7729/jvalde@fiu.edu.

IRB CONTACT INFORMATION
If you would like to talk with someone about your rights pertaining to being a subject in this
project or about ethical issues with this project, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. By
clicking on the “consent to participate” button below I am providing my informed consent.
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Appendix E: QI Project Survey

Pretest and Posttest Questionnaire:
Sphenopalatine Ganglion Blocks for treatment of Postdural Puncture Headache
INTRODUCTION
The primary aim of this QI project is to enhance the knowledge of CRNAs pertaining to the
use of Sphenopalatine Ganglion Blocks (SPGB) as a treatment alternative for Postdural Puncture
Headache (PDPH).
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format and are meant to measure knowledge and perceptions on
Sphenopalatine Ganglion Blocks as a treatment alternative for Postdural Puncture Headache.
PERSONAL INFORMATION
1. Gender: Male
2. Age: 25-35

Female

Non-binary

Prefer not to answer

36-45 46-55 56-65 >65

3. Ethnicity:
Hispanic

Caucasian (non-Hispanic)

African American Asian

Other_____________
4. Position/Title:
Certified Registered Nurse Anesthetist

MD Anesthesia

Other anesthesia

provider
5. Level of Education: Associates
Doctorate

Bachelors

Other
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Masters

6. How many years have you been in practice as an anesthesia provider?
1-2 years

2-5 years

5-10 years
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Over 10

QUESTIONNAIRE
1. The most common complication resulting from neuraxial anesthesia is:
a. infection
b. cerebral hemorrhage
c. postdural puncture headache
d. acute/chronic back pain
2. Consequences of postdural puncture headache (PDPH) include:
a. Malpractice claims
b. Increased costs
c. Subsequent hospital visits
d. Increased length of stay
e. Decreased patient satisfaction
f. All of the above
3. The hallmark postdural puncture headache (PDPH) is:
a. Nausea/vomiting
b. photophobia
c. postural component
d. dizziness
4. The Sphenopalatine Ganglion is located in the:
a. ischial tuberosity
b. temporomandibular joint
c. pterygopalatine fossa
d. eustachian tube
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5. The major parasympathetic outflow of the Sphenopalatine Ganglion causes?
a. Vasoconstriction of the cranial blood vessels
b. Vasodilation of the cranial blood vessels
c. Vasodilation of peripheral blood vessels
d. Vasoconstriction of peripheral blood vessels
6. What is the current gold standard treatment of postdural puncture headache
(PDPH)?
a. Greater Occipital Nerve Block
b. Bed rest, caffeine, and oral analgesics
c. Acupuncture
d. Epidural morphine
e. Epidural Blood Patch
7. Which Sphenopalatine Ganglion Block (SPGB) techniques is the least invasive:
a. transnasal topical
b. transnasal injection
c. transoral
d. infrazygomatic
8. Postdural puncture headache (PDPH) is suspected to result from
a. Blood in the subarachnoid space
b. Intracranial hypotension resulting from decreased Cerebrospinal fluid
c. Intracranial hemorrhage
d. An electrolyte imbalance
9. Sphenopalatine Ganglion Block (SPGB) works by
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a. Numbing the brain
b. Blocking the parasympathetic outflow of the cerebral vasculature
c. Vasodilating the blood vessels in the nose
d. Increasing production of cerebrospinal fluid
10. Sphenopalatine Ganglion Block (SPGB) has been shown to improve the treatment
for postdural puncture headache (PDPH) by?
a. Decreased Visual Analog Scale (VAS) pain scores
b. Improved patient readiness for discharge
c. A significant decrease in onset of pain relief
d. All of the above
11. How likely are you to use alternative methods for postdural puncture headache
(PDPH) treatment?
a. Most likely
b. Somewhat likely
c. Neither likely nor unlikely
d. Somewhat unlikely
e. Most unlikely
12. How likely are you to recommend Sphenopalatine Ganglion Block?
a. Most likely
b. Somewhat likely
c. Neither likely nor unlikely
d. Somewhat unlikely
e. Most unlikely
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Appendix F: Table with Overview of Literature Review Results
Author(s)

Purpose

Yilmaz et
al., (2020)

To evaluate
the effects
of a
transnasal
sphenopala
tine
ganglion
block
(SPGB) as
supportive
PDPH
treatment.

Kumar et
al., 2021

To see if
the
sphenopala
tine
ganglion
block
(SPGB) is
beneficial
for the
treatment
of PDPH in
comparison
to
conservativ
e
manageme
nt or not.

Methodolo
gy/
Research
Design
prospective
randomized
study

prospective,
randomized,
observation
al study

Intervention(s)
/ Measures

Sampling/Sett
ing

Primary Results

Relevant
Conclusions

The enrolled
subjects were
randomly
assigned to 2
groups: a
medical
treatment group
(n=10) and a
group that
would receive
medical
treatment with
the addition of
SPGB (n=10).
Visual analog
scale (VAS)
scores were
recorded at the
time of
admission, and
at 4, 12, and 24
hours after
treatment.
Included 60
patients,
divided into
three groups of
20 each. Group
C patients were
managed
conservatively.
Group L4
patients were
given SPGB
with 4%
lignocaine per
SPGB. Group
L10 patients
were given
SPGB with

Pregnant
women
undergoing a
cesarean
section under
spinal
anesthesia who
developed
PDPH

The mean VAS
values at the
baseline, 12th hour,
and 24th hour were
similar between the
groups. However,
the mean VAS
score at the fourth
hour was
significantly lower
in the block group
(p=0.002).

A unilateral
SPGB is a
rapid and
effective
method to
treat PDPH.

Indira Gandhi
Institute of
Medical
Sciences,
India.

There was a
statistically
significant
reduction in VAS
score and mean
treatment duration
in group L4 and
group L10 in
comparison to
group C. At 72 h of
treatment, 5.26% of
Group C patients,
88.89% of Group
L4, and 95% of
Group L10 patients
were found ready to
discharge. The

SPGB
increases the
proportion of
patients ready
to discharge at
72 h of
treatment.
Lignocaine
10% is more
effective than
lignocaine 4%
solution for
SPGB. SPGB
decreases the
hospital stay,
hence
cost-effective.

60 patients of
American
Society of
Anesthesiologi
sts Grades I
and II, aged
between 18
and 60 years,
undergoing
SAB for
various
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Puthenve
etitil et
al., (2018)

The
primary
objective
of this
study was
to assess
the efficacy
of SPGB
for
treatment
of PDPH.
Secondary
objectives
were to
assess
onset of
analgesia,
duration of
block and
adverse
effects.

Prospective
unblinded
observation
al study

lignocaine 10%
puffs. The
patients were
assessed at
predefined
durations for
Visual Analog
Scale (VAS)
score, readiness
to discharge,
and feel-good
index. SPSS
20.0 software
was used for
data analysis.
Of the two
consultants in
the obstetric
unit in the
institute, one of
them was
treating PDPH
with SPGB and
the other was
treating it with
conservative
measures. So,
the study was
planned as an
observational
study to
compare the
efficacy of
these two
existing
practices in the
institute in
relieving
PDPH. Group A
patients
received
paracetamol 1 g
thrice daily
intravenously
for a day. If
adequate pain

surgeries who
developed
postoperative
PDPH. They
were divided
into three
groups,
consisting of
20 in each by
computergenerated
randomization
method.

feel-good index
was assessed after
15 min of treatment
was found best in
Group L10,
followed by L4 and
C groups.

Patients with
active PDPH
within 7 days
after
subarachnoid
block not
relieved with
standard
treatment such
as intravenous
fluids,
abdominal
binder, bed rest
and caffeine
were recruited
into the study.
20 obstetric
patients from
March 2016 to
September
2017. patients
were allocated
equally to
either of the
two groups, A
and B; there
was no
randomisation
or blinding.

About 88.89%
patients in group B
had adequate pain
relief within 5 min
of block (P <
0.001). Pain was
significantly lower
in Group B for up
to 8 h, with no
adverse effects. In
group A, the
median pain score
was ≥4 up to 2 h
and from 4–24 h
the median pain
score remained <4.
In group B after the
block was
performed, the
median pain score
was <4 up to 4h and
then rose to 4 at 6h
and subsequently it
was maintained at
<4 throughout the
study period. While
comparing the
median pain score,
it was seen that
from 30min to 4h,
group A had
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SPGB is an
effective
initial
modality for
managing
severe
headache in
patients with
PDPH.

relief was not
achieved,
intravenous
diclofenac 75
mg twice daily
was added.
Patients in
group B
received
spheno-palatine
block, which
was performed
in the intensive
care unit.

Takmaz
et al.,
(2021)

This study
investigate
d the
efficacy
and safety
of
transnasal
sphenopala
tine
ganglion
block
(SPGB) for
treatment
of postural
puncture
headache
(PDPH) in
nonobstetric
patients

retrospectiv
e study

significantly higher
pain score whereas
from 6 to 8h, group
A had significantly
lower pain score
than group B.
Though the trend
remained the same
from 8 to 12 h, the
difference was not
statistically
significant. Median
was also used to
analyse pain score,
other than mean, as
most of patients in
Group B had a pain
score of zero.
The study was
26 nonHeadache at 15
conducted at the obstetric
min post-procedure
Ankara
patients (age,
was relieved
Research and
≥18 years) who rapidly. At 24 h
Educational
were
post-procedure,
Hospital, in
diagnosed with nearly half of
Turkey.
PDPH and
patients (42.3%)
unresponsive
had no pain, and all
Transnasal
to conservative patients (100%) had
SPGB was
therapy or
a VAS score of < 3.
performed in
unable to
each nostril.
continue it
According to the
Pain severity
because of side PGIC scale scores
was assessed
effects.
at 48 h postwith the Visual
procedure, 73.1%
Analogue Scale
of patients
(VAS) at 15
evaluated
min, 30 min, 24
themselves as
h, and 48 h after
“much improved”
the procedure,
and 26.9%
while patients
evaluated
were seated.
themselves as “very
The patients
much improved”
were monitored
for 48 h for
adverse effects
(AEs). Patient
treatment
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When PDPH
does not
respond to
conservative
treatment, it
may be treated
effectively
with
transnasal
SPGB, which
is a
noninvasive,
safe, welltolerated, and
straightforwar
d method with
a low
complication
rate

Khawaja
et al.,
(2019)

To evaluate Case series.
the efficacy
of a new&
novel
technique
Sphenopala
tine
Ganglion
Block
(SPG) for
the
treatment
of post
duralpunct
ural
headache
(PDPH)

satisfaction was
assessed at 48 h
after the
procedure by
using the
Patient Global
Impression of
Change (PGIC)
scale
Total of 53
patients of
PDPH fulfilling
inclusion
criteria were
offered SPG
block and their
response was
quantified on
visual analogue
scale (VAS)
from 0-10

The study was
conducted at
department of
Anesthesiology
, pain and
intensive care,
Combined
Military
Hospital,
Skardu, from
Mar to Oct
2017.
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Out of total n=53
all the patients were
females, the age of
the patients were
between 18-37
years, with the
mean of 27.08 and
± SD of 5.188),
VAS score before
undergoing SPG
block was between
8 and 10 with the
mean of 9.377 ± SD
0.664. For the
patients after
undergoing SPG
block significant
decrease on mean
i.e. 1.175 with ±SD
0.657 was noted
with p-value

SPG block
was found
more
innovative
modality for
treating post
duralpunctural
headache.

Appendix G: QI Educational Module
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